Phenotyping and Characterization of wtATTR-CM (TRACE 1)
Phenotyping and Characterization of Danish Wild-type Transthyretin Amyloidosis Cardiomyopathy Patients: A Cross-sectional Study
Steen Hvitfeldt Poulsen
120 participants
Feb 20, 2024
OBSERVATIONAL
Conditions
Summary
Descriptive cross-sectional study on 100 consecutive ATTRwt-CM patients reflecting all NAC stages aiming primarily to investigate ATTRwt-CM patient's quality of life (QoL) measures and their relation to ATTRwt-CM severity. Secondarily aiming to investigate the possibility to measure misTTR and fragTTR in plasma and urine and to detect fragTTR in endomyocardial biopsies from ATTRwt-CM patients. To investigate whether misTTR and fragTTR levels are correlated with ATTRwt-CM severity.
Eligibility
Inclusion Criteria7
- Group 1: wtATTR-CM patients
- Patients \> 18 years diagnosed with ATTRwt-CM by:
- endomyocardial biopsy
- DPD scintigraphy with Perugini grade 2-3 where variant amyloidosis is ruled out due to genetic testing.
- Informed oral and written consent
- Patients \> 18 years
- Informed oral and written consent
Exclusion Criteria16
- AL amyloidosis (light-chain amyloidosis).
- Myelomatosis
- Waldenström macroglobulinemia
- Group 2: Control group
- Known cardiovascular disease including ischemic heart disease, heart failure, atrial fibrillation, presence of a pacemaker, or malignant hypertension. Well-controlled hypertension is acceptable.
- Suspicion of cardiac amyloidosis assessed through clinical history, physical examination, ECG, and echocardiography focusing on "red flags":
- Echocardiography with:
- Myocardial hypertrophy (septum \>11 mm)
- Apical sparing in LV-GLS
- Infiltrative changes in the right ventricle free wall, thickened atrioventricular valves, or thickened atrial septum
- Symptoms of polyneuropathy
- Low voltage on ECG or discrepancy between left ventricular thickness and ECG amplitude indicative of low voltage
- Atrioventricular block (AV block)
- Bilateral carpal tunnel syndrome
- Surgery for spinal stenosis
- Elevated troponin I or NT-pro-BNP
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06291805